Abbott, MSD Pharmaceuticals ink distribution pact for oral anti-diabetic medicines in India

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD's sitagliptin, its combination sitagliptin/metformin, and the extended-release version, marketed as Januvia, Janumet, and Janumet XR. This collaboration aims to leverage Abbott's extensive reach to ensure continued access to these diabetes treatments for the large diabetic and pre-diabetic population in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EYXHb27
via IFTTT